Table 1.
Factor | Value | Percentage |
---|---|---|
Age (at diagnosis), in years | ||
Mean | 58.006 | |
Median | 58 | |
Range |
15–90 |
|
Gender | ||
Male | 280 | 62.36 |
Female |
169 |
37.63 |
Ethnicity | ||
Non-Hispanic/Non-Latino | 426 | 94.88 |
Hispanic/Latino | 10 | 2.23 |
Unknown |
13 |
2.90 |
Race | ||
White | 426 | 94.88 |
Black/African American | 1 | 0.22 |
Asian | 12 | 2.67 |
Unknown |
10 |
2.23 |
Known primary melanoma tumor | ||
Yes | 402 | 89.53 |
No |
47 |
10.47 |
Location of primary melanoma | ||
Head and Neck | 35 | 7.80 |
Trunk | 155 | 34.52 |
Extremity | 194 | 43.21 |
Other | 13 | 2.90 |
Unknown |
52 |
11.58 |
Breslow thickness (mm) | ||
Mean | 5.49 | |
Median | 3 | |
Unknown |
105 |
23.39 |
Clark level | ||
I–III | 98 | 21.83 |
IV–V | 211 | 46.99 |
Unknown |
140 |
31.18 |
Ulceration status | ||
Yes | 159 | 35.41 |
No | 141 | 31.40 |
Unknown |
149 |
33.18 |
Mitotic rate | ||
<1 | 19 | 4.23 |
≥ 1 | 151 | 33.63 |
Unknown |
279 |
62.14 |
T stage | ||
Tis | 7 | 1.56 |
T0 | 23 | 5.12 |
T1 | 10 | 2.23 |
T1a | 22 | 4.90 |
T1b | 10 | 2.23 |
T2 | 30 | 6.68 |
T2a | 31 | 6.90 |
T2b | 15 | 3.34 |
T3 | 14 | 3.12 |
T3a | 37 | 8.24 |
T3b | 37 | 8.24 |
T4 | 15 | 3.34 |
T4a | 23 | 5.12 |
T4b | 104 | 23.16 |
TX | 44 | 9.80 |
Unknown |
27 |
6.01 |
N stage | ||
N0 | 223 | 49.67 |
N1 | 16 | 3.56 |
N1a | 18 | 4.01 |
N1b | 38 | 8.46 |
N2 | 6 | 1.34 |
N2a | 13 | 2.90 |
N2b | 20 | 4.45 |
N2c | 9 | 2.00 |
N3 | 53 | 11.80 |
NX | 34 | 7.57 |
Unknown |
19 |
4.23 |
M stage | ||
M0 | 400 | 89.09 |
M1 | 5 | 1.11 |
M1a | 4 | 0.89 |
M1b | 5 | 1.11 |
M1c | 9 | 2.00 |
Unknown |
26 |
5.79 |
Pathological Stage | ||
Stage 0 | 6 | 1.34 |
Stage I | 30 | 6.68 |
Stage IA | 18 | 4.01 |
Stage IB | 29 | 6.46 |
Stage II | 30 | 6.68 |
Stage IIA | 17 | 3.79 |
Stage IIB | 27 | 6.01 |
Stage IIC | 58 | 12.92 |
Stage III | 40 | 8.91 |
Stage III A | 15 | 3.34 |
Stage III B | 45 | 10.02 |
Stage III C | 66 | 14.70 |
Stage IV | 22 | 4.90 |
I/II NOS | 10 | 2.23 |
Unknown |
36 |
8.02 |
Anatomic site | ||
Primary Tumor | 91 | 20.27 |
Regional Lymph Node | 218 | 48.55 |
Regional Cutaneous or Subcutaneous tissue | 73 | 16.26 |
Distant Metastasis | 64 | 14.25 |
Unknown |
3 |
0.67 |
Overall Survival (months) | ||
Mean | 52.96 | |
Median | 29.5 | |
Range |
0–362.33 |
|
Vital Status | ||
Alive | 295 | 65.70 |
Dead | 154 | 34.30 |